Dmitri V. Lissin
Technik-/Wissenschafts-/F&E-Leiter bei SCILEX HOLDING COMPANY
Aktive Positionen von Dmitri V. Lissin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SCILEX HOLDING COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Direktor/Vorstandsmitglied | 10.07.2015 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 | - | |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2019 | - |
Karriereverlauf von Dmitri V. Lissin
Ehemalige bekannte Positionen von Dmitri V. Lissin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
XENOPORT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2011 | 01.08.2015 |
Ausbildung von Dmitri V. Lissin
Russian National Research Medical University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCILEX HOLDING COMPANY | Health Technology |
Private Unternehmen | 3 |
---|---|
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
- Börse
- Insiders
- Dmitri V. Lissin
- Erfahrung